Radiotherapy and immunotherapy combination in head and neck cancer: Does current failure qualify as an ending or is it a key to future success?

• Radiation/immunotherapy combination in head and neck cancer is a tempting approach. • Published phase III trials have yielded disappointing results. • Possible reason for failure might be timing sequencing of radiation and immunotherapy. • The interplay between radiation and immunotherapy is not completely understood.